Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein

D Oyen, JL Torres, U Wille-Reece… - Proceedings of the …, 2017 - National Acad Sciences
Acquired resistance against antimalarial drugs has further increased the need for an
effective malaria vaccine. The current leading candidate, RTS, S, is a recombinant …

Prevalence and risk factors associated with asymptomatic malaria among school children: repeated cross-sectional surveys of school children in two ecological zones …

BA Mensah, JL Myers-Hansen, E Obeng Amoako… - BMC Public Health, 2021 - Springer
Abstract Background Asymptomatic Plasmodium infections significantly drive malaria
transmission and impact control and elimination strategies, but are largely uncharacterized …

The P. falciparum CSP repeat region contains three distinct epitopes required for protection by antibodies in vivo

Y Flores-Garcia, LT Wang, M Park, B Asady… - PLoS …, 2021 - journals.plos.org
Rare and potent monoclonal antibodies (mAbs) against the Plasmodium falciparum (Pf)
circumsporozoite protein (CSP) on infective sporozoites (SPZ) preferentially bind the PfCSP …

First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly …

JN Hutter, PM Robben, C Lee, M Hamer, JE Moon… - Vaccine, 2022 - Elsevier
The global burden of malaria remains substantial. Circumsporozoite protein (CSP) has been
demonstrated to be an effective target antigen, however, improvements that offer more …

Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum

T Pholcharee, D Oyen, Y Flores-Garcia… - Nature …, 2021 - nature.com
The most advanced P. falciparum circumsporozoite protein-based malaria vaccine, RTS,
S/AS01 (RTS, S), confers partial protection but with antibody titers that wane relatively …

Cryo-EM structure of P. falciparum circumsporozoite protein with a vaccine-elicited antibody is stabilized by somatically mutated inter-Fab contacts

D Oyen, JL Torres, CA Cottrell, C Richter King… - Science …, 2018 - science.org
The circumsporozoite protein (CSP) on the surface of Plasmodium falciparum sporozoites is
important for parasite development, motility, and host hepatocyte invasion. However …

Restricted valency (NPNA)n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum

MD Langowski, FA Khan, S Savransky, DR Brown… - npj Vaccines, 2022 - nature.com
Abstract The Circumsporozoite Protein (CSP) of Plasmodium falciparum contains an N-
terminal region, a conserved Region I (RI), a junctional region, 25–42 copies of major …

Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection

KE Seaton, RL Spreng, M Abraha, M Reichartz… - npj Vaccines, 2021 - nature.com
Abstract RTS, S/AS01 is an advanced pre-erythrocytic malaria vaccine candidate with
demonstrated vaccine efficacy up to 86.7% in controlled human malaria infection (CHMI) …

estMOI: estimating multiplicity of infection using parasite deep sequencing data

SA Assefa, MD Preston, S Campino, H Ocholla… - …, 2014 - academic.oup.com
Individuals living in endemic areas generally harbour multiple parasite strains. Multiplicity of
infection (MOI) can be an indicator of immune status and transmission intensity. It has a …

Epitope-coated polymer particles elicit neutralising antibodies against Plasmodium falciparum sporozoites

BJ Evert, S Chen, R McConville, RWJ Steel, J Healer… - npj Vaccines, 2021 - nature.com
Abstract The current Malaria RTS, S vaccine is based on virus-like particles (VLPs)
comprising the NANP repetitive epitopes from the cicumsporozoite protein (CSP) of …